Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BraveCX

K-Number: K223754 · 2023-11-09

ApplicantBering, Ltd.
Decision Date2023-11-09
Product CodeQFM
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

BraveCX is the device name listed in this FDA 510(k) record. The listed applicant is Bering, Ltd.. It received FDA 510(k) clearance on 2023-11-09 under 510(k) number K223754. The device is classified under product code QFM. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BraveCX?

BraveCX is a medical device that received FDA 510(k) clearance on 2023-11-09. The listed applicant is Bering, Ltd.. The 510(k) number is K223754.

When did BraveCX receive FDA 510(k) clearance?

BraveCX received FDA 510(k) clearance on 2023-11-09, under 510(k) number K223754.

Who is the listed applicant for BraveCX?

The FDA 510(k) record lists Bering, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BraveCX?

The FDA product code for BraveCX is QFM.

Related Devices (Code: QFM)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253751CXRDetectAINeurocareai, Inc. (Dba Savelife.Ai)K252954MammoSightAINeurocareai, Inc. (Dba Savelife.Ai)K252482CogNet AI-MT+Medcognetics, Inc.K250831Annalise EnterpriseAnnalise-AiK243808Rayvolve PTX-PEAZmedK243548BriefCase-TriageAidoc Medical , Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑